PRINCETON, N.J., May 14, 2015 /PRNewswire/ -- Prophecy Inc. (www.prophecyinc.com) today announced the launch of a public prediction market platform to enable participants from the healthcare and investor communities to predict the outcomes of regulatory events for investigational new drugs submitted for marketing approval. The prediction markets will also probe related events, such as clinical trial outcomes, product sales and prescription rates. The prediction markets are deployed in Prophecy's secure, proprietary, cloud-based platform.
All industry and academic professionals can apply for an account and predict anonymously at http://www.prophecyinc.com/predict.html. The predicted probabilities of this "wise crowd" of participants on drug approvals and related outcomes will be available and visible to all participants.
Prizes Are Awarded to Help Drive Predictive Power:
For each prediction contest Prophecy is awarding prizes to winning participants. Prophecy anticipates that healthcare industry professionals, financial professionals, academics and others with diverse relevant expertise will participate and drive predictive power.
The Wisdom of Wise Crowds SM:
Prophecy's goal is to harness the Wisdom of Wise Crowds to predict outcomes of events of key societal and commercial interest and impact. It does this both through public prediction market contests, such as the newly launched platform directed at events related to pharmaceutical product approvals, and on behalf of corporate, non-profit and academic clients of its crowd-sourcing enabled consulting services.
About Prophecy Inc.:
Prophecy was founded based on a proprietary methodology for harnessing the wisdom of crowds in settings with a limited number of participants originally developed by Merck Research Laboratories. Prophecy focuses today on providing technology enabled services to the healthcare industry leveraging crowd-sourcing approaches to guide corporate decision-making and resource allocation. The company's principals and team-members have deep and broad experience in biotech and pharmaceutical industries, healthcare IT, simulation sciences and data analytics. The company's clients include fortune 500 companies.
SOURCE Prophecy Inc.